Holen Sie sich die Stockscreener-App
2.235
0.45%
-0.005
Schlusskurs vom Vortag:
$2.24
Offen:
$2.21
24-Stunden-Volumen:
418.65K
Relative Volume:
0.78
Marktkapitalisierung:
$204.00M
Einnahmen:
$25.14M
Nettoeinkommen (Verlust:
$-21.57M
KGV:
-8.2778
EPS:
-0.27
Netto-Cashflow:
$-12.23M
1W Leistung:
-18.01%
1M Leistung:
-26.89%
6M Leistung:
+9.31%
1J Leistung:
+6.70%
1-Tages-Spanne:
$2.12
$2.24
1-Wochen-Bereich:
$2.12
$2.89
52-Wochen-Spanne:
$1.54
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Vergleichen Sie STXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.24 | 209.05M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
558.98 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.54 | 55.33B | 21.84B | 1.68B | 2.55B | 5.8322 |
|
ALC
Alcon Inc
|
77.96 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
247.32 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
262.62 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2022-07-12 | Eingeleitet | Aegis Capital | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2022-01-05 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | Loop Capital | Buy |
| 2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-08 | Eingeleitet | Northland Capital | Outperform |
| 2020-04-09 | Eingeleitet | Cowen | Outperform |
| 2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Is Stereotaxis Inc. stock attractive for growth fundsPortfolio Profit Report & High Yield Equity Trading Tips - newser.com
How Stereotaxis Inc. stock correlates with oil marketsPortfolio Growth Summary & High Accuracy Swing Entry Alerts - newser.com
How rising interest rates impact Stereotaxis Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Stereotaxis Inc. stock momentum explainedWeekly Trend Summary & Community Driven Trade Alerts - newser.com
What technical models suggest about Stereotaxis Inc.’s comebackMarket Trend Summary & Consistent Income Trade Ideas - newser.com
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics - sharewise.com
Why Stereotaxis Inc. stock could see breakout soonWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
How strong is Stereotaxis Inc. stock balance sheetDay Trade & Daily Technical Stock Forecast Reports - newser.com
Stereotaxis, Inc. (AMEX:STXS) Q3 2025 Earnings Call Transcript - Insider Monkey
FDA clearances: Fujifilm Sonosite, Stereotaxis, Adaptix, Aiomega - Modern Healthcare News
Can Stereotaxis Inc. stock retain market dominanceShort Setup & Long Hold Capital Preservation Plans - newser.com
Why Stereotaxis Inc. stock could outperform in 2025July 2025 Price Swings & Weekly Breakout Stock Alerts - newser.com
Using AI based signals to follow Stereotaxis Inc.Market Sentiment Report & AI Forecast Swing Trade Picks - newser.com
Will Stereotaxis Inc. stock maintain growth storyWeekly Risk Summary & AI Optimized Trading Strategy Guides - newser.com
Stereotaxis, Inc. SEC 10-Q Report - TradingView
Biggest stock movers Wednesday: AMD, ALC, and more (NYSE:STXS) - Seeking Alpha
Is Stereotaxis Inc. stock trading near support levels2025 Price Action Summary & AI Based Trade Execution Alerts - newser.com
Stereotaxis (STXS) Shares Drop After Wider Loss and Revenue Miss - GuruFocus
Stereotaxis nets FDA clearance for redesigned surgical robot - Yahoo Finance
Stereotaxis shares drop after Q3 loss widens, GenesisX limited launch underway (STXS:NYSE) - Seeking Alpha
Stereotaxis Inc (STXS) Q3 2025 Earnings Call Highlights: Navigat - GuruFocus
Stereotaxis Inc (STXS) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst Financial ... - Yahoo Finance
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates - sharewise.com
Earnings call transcript: Stereotaxis Q3 2025 misses revenue forecast, stock gains - Investing.com
Stereotaxis (STXS) Reports Q3 Revenue Below Expectations - GuruFocus
Stereotaxis earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada
Stereotaxis Q3 Loss Narrows, Revenue Declines - MarketScreener
Stereotaxis Bets On Growth Despite Recent Losses - Finimize
Stereotaxis Q3 2025 Earnings Call Transcript - MarketBeat
Stereotaxis shares tumble as Q3 revenue misses estimates, outlook disappoints By Investing.com - Investing.com South Africa
Stereotaxis shares tumble as Q3 revenue misses estimates, outlook disappoints - Investing.com India
Stereotaxis Reports 2025 Third Quarter Financial Results - The Manila Times
Robotic surgery firm Stereotaxis's Q3 net loss widens - MarketScreener
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.02%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):